Deprecated: Function eregi() is deprecated in /home2/tmps1234/public_html/includes/session.inc.php on line 10

Warning: session_start(): Cannot send session cookie - headers already sent by (output started at /home2/tmps1234/public_html/includes/session.inc.php:10) in /home2/tmps1234/public_html/includes/session.inc.php on line 21

Warning: session_start(): Cannot send session cache limiter - headers already sent (output started at /home2/tmps1234/public_html/includes/session.inc.php:10) in /home2/tmps1234/public_html/includes/session.inc.php on line 21

Deprecated: mysql_connect(): The mysql extension is deprecated and will be removed in the future: use mysqli or PDO instead in /home2/tmps1234/public_html/includes/dbinitialize.inc.php on line 23
Patents published on the Journal dated: 2010-02-26 - Patents India - TMPsearchers.com
IPR Consultants Attorneys Agents in India
India Trademark Registration and Search India Patent Search and Registration


Trademark Registration
India Patent Search
Free Patent Search
India Trademark Registration
Free Trademark Search
Trademark Search India
Registered Trademark
Patent Outsourcing



Payment
Guarantee



A tribute to
Sri.N.R.Natarajan






Jewelry Trademark
California Trademark Registration
Federal Trademark Registration
Bio Technology

Online Watch
Logos Registration
TM number Registration
Intellectual Property Right


Browse Indian Patents by Weekly Journals
Patent Consulting Blog



Privacy Policy

®


Patents published on the Journal dated: 2010-02-26



513 Patents published on ' 2010-02-26'


A METHOD FOR DEVELOPING A TISSUE PROTEOME LIBRARY
The present invention relates to the description of an approach for developing tissue proteome library, which overexpresses all the transcripts (mRNAs) present in a given tissue. Transcripts of interest present in a tissue are normally cloned and


PHARMACEUTICAL FORMULATION COMPRISING (R)-BICALUTAMIDE
A pharmaceutical formulation comprising 4-cyano-α,α,α-trifluoro-3-(4-fluorophenylsulphonyl)-2 -hydroxy-2-methylpropiono-m-toluidide in a solid dispersion comprising an enteric polymer having apKa from 3 to 6, wherein greater than 50% of the 4-


VEGF-SPECIFIC ANTAGONISTS FOR ADJUVANT AND NEOADJUVANT THERAPY AND THE TREATMENT OF EARLY STAGE TUMORS
Disclosed herein are methods of treating benign, pre-cancerous, or non-metastatic tumors using an anti-VEGF-specific antagonist. Also disclosed are methods of treating a subject at risk of developing benign, pre-cancerous, or non-metastatic tumors


TREATMENT OF WASTEWATER BY CONSTRUCTED WETLANDS
The invention relates with the treatment of wastewater by passing it through a bed made after constructing a masonry tank or excavating a ditch of designed dimensions and filled with graded gravel and sand of specified size serving as a filter media


WATER SOLUBLE REACTIVE DERIVATIVES OF CARBOXY POLYSACCHARIDES AND FIBRINOGEN CONJUGATES THEREOF
The present invention provides water-soluble reactive esters of carboxy polysaccharides and derivatives thereof. The reactive carboxy polysaccharide derivatives are useful per se in aqueous solutions or specifically for the formation of


COMPOSITE SINTERED BODY
The composite sintered body of the invention is a composite sintered body, containing 20 volume % or more and 80 volume % or less of cubic boron nitride particles, and a binder; wherein the binder contains at least one selected from the group


IMMUNOPOTENTIATING COMPOSITION FROM LABISIA PUMILA EXTRACT
The present invention relates to an immunopotentiating composition and to a composition accelerating the production of interferon-[gamma]. More particularly to a process for preparation of water-soluble Labisia pumila extract and the use of said


BATTERY POWERED CHARGER
A charger for recharging the batteries of a portable electronic device even when no external po wer source is available. A battery or cell is installed within the charger, and when no access is available to a fixed po wer source into which the


2-ETHOXY-3-PHENYLPROPIONIC ACID DERIVATIVES FOR THE TREATMENT OF LIPID DISORDERS
A co mpound of formula (I) wherein T represents O, S or NR and wherein R represents a H, a C|.6alkyl group or a phenyl Ci.ealkyl group and pharmaceutically acceptable salts thereof, processes for preparing such compounds, their the utility in


NOVEL USE OF (-)-EPIGALLOCATECHIN GALLATE
Use of (-)-epigallocatechin gallate and/or one or more of its derivatives for increasing the desire, willingness and/or motivation of animals (including humans), especially mammals, to exercise, to perform and/or to run, especially to perform



Prev [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34]  35  [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] Next

Deprecated: Function eregi() is deprecated in /home2/tmps1234/public_html/patdb/footer.inc.php on line 9


Home     Free Patents     Services     Register     Contact    



We do not practice Law, do not offer any Legal Opinion and the information provided is not intended to be Legal advice and must not be taken as such. Data mining and presentation of information collected from various database searches is the service provided. See the detailed Disclaimer here and our terms of service. No copyright is claimed for Government works. Only Government work in public domain is republished here for easier and better accessibility and for research purposes as free information to the public.